✦ LIBER ✦

PCV4 COST AND OUTCOME ANALYSIS COMPARING PTCA & CABG IN LOW AND HIGH RISK PATIENTS

✍ Scribed by Singh, S; Malhotra, S; Tiwari, P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and cost-effectiveness of MIDCABG

✍ Dario F Del Rizzo; W.Douglas Boyd; Richard J Novick; F.Neil McKenzie; Nemish D D 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 340 KB

The interplay between risk attitudes and

✍ Gerst, Michael D.; Howarth, Richard B.; Borsuk, Mark E. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Transcatheter Aortic Valve Replacement i

✍ Rankin, J.; Yong, G.; Geelhoed, E.; Gardner, C.; Sanfilippo, F. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

PCV16 ROSUVASTATIN IS MORE COST-EFFECTIV

✍ RL Ohsfeldt; SK Gandhi; KM Fox; T Stacy; JM McKenney 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

Tibial Angioplasty for Limb Salvage in H

✍ Werneck, Christiane C.F.; Lindsay, Thomas F. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 370 KB

CN4 COST-EFFECTIVENESS (CE) ANALYSIS OF

✍ M Ding; Y Xing; T Shih; D Cox; S Cantor; J Cormier 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB